Name: CRMD Income Statement - Cormedix Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CRMD - Cormedix Inc.

USD | NASDAQ | Healthcare

CRMD Income Statement - Cormedix Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	127.4	128.6	104.3	39.7	39.1	-	11.5	0.8	-	-	-	-	-	0.0	0.0	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenues
Revenues	400.1	311.7	43.5	-	0.1	0.2	0.2	0.3	0.4	0.3	0.2	0.2	0.2	0.0	0.0	-	-	-	-
Cost of Revenue	32.5	22.1	3.0	-	0.0	0.1	0.2	0.4	0.4	0.1	0.4	(0.3)	(0.4)	(0.2)	0.0	-	-	-
Gross Profit	367.5	289.6	40.4	-	0.1	0.0	0.0	(0.1)	0.0	0.2	(0.1)	0.5	0.6	0.2	0.0	-	-
Operating Expenses
Research & Development	23.4	19.3	3.9	13.2	10.7	13.1	13.4	11.1	18.8	24.5	15.7	6.3	1.3	1.2	1.1
Operating Income
Operating Income	193.7	150.1	(22.4)	(49.0)	(30.6)	(29.4)	(27.2)	(21.0)	(26.9)	(32.9)	(24.8)	(16.7)	(8.9)	(4.9)
Non-Operating
Interest Income	-	3.8	2.6	2.7	0.3	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
Tax & Net
Income Tax Expense	4.0	(13.0)	(1.4)	-	(0.6)	(1.3)	(5.2)	(5.1)	-	-	-	-	-	0.0	0.0
Per Share
EPS Basic	2.28	2.25	(0.30)	(0.91)	(0.74)	(0.75)	-	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	-	150.8	(22.2)	(48.9)	(30.5)	(29.4)	(27.1)	(20.9)	(26.8)	(32.9)	(24.7)	(16.6)	(8.9)	(4.9)	(3.0)	(7.2)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	7.2	8.6	5.1	2.4	3.2	1.7	0.7	0.7	0.8	2.3	2.7	4.8	3.4	2.8	2.3	3.2	2.3	3.2	4.7	2.5	2.6	2.3	2.9	5.7	2.5	2.7	2.5	3.0	2.9	(4.3)	8.3	6.6	8.3	8.5	6.0	5.1	4.9	4.0	6.8	2.8
Selling General & Administrative	-	-	-	-	-	-	-	-	15.0	13.4	7.8	7.0	7.6	5.6	4.6	5.1
Selling & Marketing	12.5	16.0	11.2	6.4	4.5	8.3	6.7	7.4	6.3	-	4.1	3.3	-	-	-	-	-
General & Administrative	21.7	23.6	25.5	9.5	9.7	7.1	6.6	7.6	8.7	-	3.7	3.8	-	-	-	-	-
Depreciation & Amortization	10.5	-	-	-	0.2	-	-	-	0.0	-	-	-	0.0	-	-	-
Amortization of Intangibles	-	-	3.6	-	0.1	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	(0.3)	-	-	-	0.5	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	41.5	48.2	41.7	18.3	17.4	17.1	14.1	15.6	15.9	15.7	10.5	11.8	11.0	8.4	7.0	8.3

Operating Income
Operating Income	63.7	59.1	51.3	19.5	20.1	12.9	(3.3)	(15.3)	(16.7)	(15.7)	(10.5)	(11.8)	(11.0)	(8.4)	(7.0)	(8.2)	(7.0)	(7.8)	(8.6)	(5.9)	(7.2)	(6.1)	(6.6)	(8.9)	(5.6)	(5.4)	(5.2)	(5.5)	(4.9)	2.1	(10.2)	(8.6)	(10.2)	(10.3)	(8.0)	(7.0)	(7.6)	(6.5)	(9.2)	(4.9)

Tax & Net
Income Tax Expense	17.0	42.4	(56.0)	0.5	0.0	-	-	-	(1.4)	-	-	-	-	-	-	(0.6)	-	-	-	(1.3)	-	-	-	(5.2)	-	-	-	(5.1)	-	-	-	0.0	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	38.6	(129.5)	108.6	2.0	20.6	13.5	(2.8)	(14.2)	(14.5)	(14.8)	(9.7)	(11.3)	(10.6)	(8.8)	(6.9)	(7.6)	(7.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	38.6	14.0	108.6	19.8	20.6	13.5	(2.8)	(14.2)	(14.5)	(14.8)	(9.7)	(11.3)	(10.6)	(8.2)	(6.9)	(7.6)	(7.0)
Net Income Attributable To Parent	38.6	14.0	108.6	19.8	20.6	13.5	(2.8)	(14.2)	(14.5)	(14.8)	(9.7)	(11.3)	(10.6)	(8.2)	(6.9)	(7.6)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	38.6	14.0	108.6	19.8	20.6	13.5	(2.8)	(14.2)	(14.5)	(14.8)	(9.7)	(11.3)	(10.6)	(37.4)	(6.9)

Per Share
EPS Basic	0.48	-	1.42	0.29	0.32	-	(0.05)	(0.25)	(0.25)	-	(0.17)	(0.25)	(0.24)	-	(0.17)	(0.19)	(0.18)	-	(0.22)	(0.12)	(0.20)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	0.43	-	1.26	0.28	0.30	-	(0.05)	(0.25)	(0.25)	-	(0.17)	(0.25)	(0.24)	-	(0.17)	(0.19)	(0.18)	-
Shares Basic	79.5	-	75.9	67.9	65.2	-	58.8	57.6	57.5	-	56.6	45.4	44.1	-	41.2	39.8	38.2	-
Shares Diluted	93.0	-	86.2	71.9	69.0	-	58.8	57.6	57.5	-	56.6	45.4	44.1	-	41.2	39.8	38.2	-

Supplementary Data
EBITDA	74.2	-	-	-	20.3	-	-	-	(16.7)	-	-	-	(11.0)	-	-	-	(7.0)	-	-	-	(7.2)	-	-	-	(5.6)	-	-	-	(4.9)	-	-	-	(10.2)	-	-	-	(7.6)	-	-	-
EBIT	63.7	59.1	51.3	19.5	20.1	12.9	(3.3)	(15.3)	(16.7)	(15.7)	(10.5)	(11.8)	(11.0)	(8.4)	(7.0)	(8.2)	(7.0)	(7.8)	(8.6)

Non-Operating
Interest Income	-	0.9	1.6	0.8	0.6	0.5	0.6	0.7	0.9	0.9	0.8	0.6	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	-	1.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(8.0)	(2.7)	1.2	0.8	0.5	0.5	0.5	1.1	0.8	0.9	0.7	0.5	0.4	0.2	0.1	0.0	(0.0)
Pre-Tax Income	55.6	56.4	52.6	20.3	20.6	13.5	(2.8)	(14.2)	(15.9)	(14.8)	(9.7)	(11.3)	(10.6)	-	(6.9)	(8.2)